COPART Risk Score, Endothelial Dysfunction, and Arterial Hypertension are Independent Risk Factors for Mortality in

G Hackl1, P Jud1, A Avian2

  • 1Department of Internal Medicine, Division of Angiology, Medical University Graz, Austria.

Insights

The COPART risk score and flow-mediated dilation (FMD) predict mortality in peripheral artery disease patients. Combining these with arterial hypertension offers the best long-term survival assessment for claudicants.

Area of Science:

  • Vascular Medicine
  • Cardiovascular Research
  • Clinical Prognostics

Background:

  • Peripheral artery disease (PAOD) significantly impacts patient prognosis.
  • The COPART risk score is a tool for assessing PAOD patient outcomes.
  • Endothelial function, measured by flow-mediated dilation (FMD), is crucial for vascular health.

Purpose of the Study:

  • To evaluate the long-term mortality prediction capabilities of the COPART risk score and FMD in patients with intermittent claudication.
  • To determine the combined predictive value of these markers for disease-specific survival.

Main Methods:

  • A prospective observational study included 184 claudicants with a median follow-up of 7.9 years.
  • Brachial FMD was measured at study inclusion to assess endothelial function.
  • Patients were stratified into low, medium, and high risk groups based on the COPART risk score.

Main Results:

  • Overall survival rates significantly differed across COPART risk score groups (p < .001).
  • Survivors exhibited significantly better FMD compared to non-survivors (p < .001).
  • COPART risk score, FMD (≤2.5 vs. >2.5), and arterial hypertension were identified as independent predictors of long-term mortality.

Conclusions:

  • The COPART risk score, FMD, and arterial hypertension are significant independent predictors of long-term mortality in claudicants.
  • Integrating these three factors provides the most accurate mortality assessment for this patient group.
  • These findings support the use of a multi-factor approach for predicting long-term outcomes in PAOD.
Abstract

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
512
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.5K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
605
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
567
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
813
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
568